Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating bone marrow–derived stem cells and granulocyte colony-stimulating factor with circulatory support for dilated cardiomyopathy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bone marrow-derived stem cells
  • G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Dilated Cardiomyopathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING